{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:50:20Z","timestamp":1790769020490,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602245"],"award-info":[{"award-number":["602245"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["ANR-10-LABX-73"],"award-info":[{"award-number":["ANR-10-LABX-73"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["ANR-11-INBS-0011"],"award-info":[{"award-number":["ANR-11-INBS-0011"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_140945"],"award-info":[{"award-number":["31003A_140945"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.omtm.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T23:15:39Z","timestamp":1494544539000},"page":"259-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing"],"prefix":"10.1016","volume":"5","author":[{"given":"Karine","family":"Cambon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Jarrige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Bugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Miniarikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymonde","family":"Hassig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenaelle","family":"Auregan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hantraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselme L.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"D\u00e9glon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2017.05.001_bib1","unstructured":"Huntington, G. (1872). On chorea. The Medical and Surgical Reporter: A Weekly Journal, (Philadelphia: SW Butler) 26, 317\u2013321."},{"key":"10.1016\/j.omtm.2017.05.001_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosome","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2017.05.001_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","article-title":"Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis","volume":"67","author":"Godin","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2017.05.001_bib4","doi-asserted-by":"crossref","first-page":"e64368","DOI":"10.1371\/journal.pone.0064368","article-title":"Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis","volume":"8","author":"Nguyen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2017.05.001_bib5","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type huntingtin protects from apoptosis upstream of caspase-3","volume":"20","author":"Rigamonti","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib6","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/emboj.2008.133","article-title":"Huntingtin phosphorylation acts as a molecular switch for anterograde\/retrograde transport in neurons","volume":"27","author":"Colin","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.omtm.2017.05.001_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cell.2012.12.029","article-title":"Vesicular glycolysis provides on-board energy for fast axonal transport","volume":"152","author":"Zala","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2017.05.001_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ydbio.2014.08.009","article-title":"Huntingtin regulates Ca(2+) chemotaxis and K(+)-facilitated cAMP chemotaxis, in conjunction with the monovalent cation\/H(+) exchanger Nhe1, in a model developmental system: insights into its possible role in Huntington\u2019s disease","volume":"394","author":"Wessels","year":"2014","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtm.2017.05.001_bib9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of Huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2017.05.001_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-0004.2011.01823.x","article-title":"The Huntington\u2019s Disease health-related Quality of Life questionnaire (HDQoL): a disease-specific measure of health-related quality of life","volume":"81","author":"Hocaoglu","year":"2012","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omtm.2017.05.001_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/YIC.0b013e3283534fa9","article-title":"Validation of the first\u00a0quality-of-life measurement for patients with Huntington\u2019s disease: the Huntington Quality of Life Instrument","volume":"27","author":"Clay","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.omtm.2017.05.001_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JHD-130051","article-title":"Quality of life in Huntington\u2019s disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners","volume":"2","author":"Read","year":"2013","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.omtm.2017.05.001_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.parkreldis.2014.12.013","article-title":"Update on Huntington\u2019s disease: advances in care and emerging therapeutic options","volume":"21","author":"Zielonka","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.omtm.2017.05.001_bib14","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.05.001_bib15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington\u2019s disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington\u2019s disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2017.05.001_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2017.05.001_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.omtm.2017.05.001_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2017.05.001_bib21","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1073\/pnas.1524575113","article-title":"Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.05.001_bib22","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.05.001_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2008.231","article-title":"Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in\u00a0vitro and in\u00a0vivo","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drudis.2014.09.011","article-title":"Delivering a disease-modifying treatment for Huntington\u2019s disease","volume":"20","author":"Godinho","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtm.2017.05.001_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2017.05.001_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.1068999","article-title":"A system for stable expression of short interfering RNAs in mammalian cells","volume":"296","author":"Brummelkamp","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.omtm.2017.05.001_bib27","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1093\/nar\/gkh790","article-title":"Relative gene-silencing efficiencies of small interfering RNAs targeting sense and antisense transcripts from the same genetic locus","volume":"32","author":"Hu","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib28","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1261\/rna.599107","article-title":"Defining the optimal parameters for hairpin-based knockdown constructs","volume":"13","author":"Li","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.omtm.2017.05.001_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/oli.2006.0069","article-title":"shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA","volume":"17","author":"Vlassov","year":"2007","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.omtm.2017.05.001_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/msb.2010.24","article-title":"Target mRNA abundance dilutes microRNA and siRNA activity","volume":"6","author":"Arvey","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.omtm.2017.05.001_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nmeth.1448","article-title":"In situ detection and genotyping of individual mRNA molecules","volume":"7","author":"Larsson","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2017.05.001_bib32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/nat.2013.0466","article-title":"Target gene abundance contributes to the efficiency of siRNA-mediated gene silencing","volume":"24","author":"Hong","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/msb.2010.89","article-title":"mRNA turnover rate limits siRNA and microRNA efficacy","volume":"6","author":"Larsson","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.omtm.2017.05.001_bib34","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/nar\/30.8.1757","article-title":"Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor","volume":"30","author":"Holen","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib35","doi-asserted-by":"crossref","first-page":"15991","DOI":"10.1074\/jbc.M300714200","article-title":"The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript","volume":"278","author":"Bohula","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2017.05.001_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2017.05.001_bib37","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1093\/nar\/gkg649","article-title":"The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides","volume":"31","author":"Kretschmer-Kazemi Far","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jmb.2005.03.012","article-title":"Local RNA target structure influences siRNA efficacy: a systematic global analysis","volume":"348","author":"Overhoff","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2017.05.001_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2199-12-34","article-title":"The effects of stem length and core placement on shRNA activity","volume":"12","author":"McIntyre","year":"2011","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.omtm.2017.05.001_bib40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia","volume":"10","author":"Xia","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2017.05.001_bib41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2005.02.024","article-title":"Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference","volume":"329","author":"Chen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2017.05.001_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/hum.2005.16.618","article-title":"Adenovirus-mediated silencing of huntingtin expression by shRNA","volume":"16","author":"Huang","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","article-title":"Clinico-pathological rescue of a model mouse of Huntington\u2019s disease by siRNA","volume":"53","author":"Wang","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2006.02.141","article-title":"rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse","volume":"343","author":"Machida","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2017.05.001_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02685888","article-title":"Investigation of RNA interference to suppress expression of full-length and fragment human huntingtin","volume":"9","author":"Gary","year":"2007","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.omtm.2017.05.001_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hum.2006.160","article-title":"High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Huang","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib47","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.05.001_bib48","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib49","doi-asserted-by":"crossref","first-page":"e99341","DOI":"10.1371\/journal.pone.0099341","article-title":"Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells","volume":"9","author":"Drouet","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2017.05.001_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-907X-2-8","article-title":"The dose can make the poison: lessons learned from adverse in\u00a0vivo toxicities caused by RNAi overexpression","volume":"2","author":"Grimm","year":"2011","journal-title":"Silence"},{"key":"10.1016\/j.omtm.2017.05.001_bib51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nbt1205","article-title":"A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells","volume":"24","author":"Marques","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2017.05.001_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/hum.2007.179","article-title":"Overcoming the innate immune response to small interfering RNA","volume":"19","author":"Judge","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nsmb.1987","article-title":"Competition for XPO5 binding between Dicer mRNA, pre-miRNA and viral RNA regulates human Dicer levels","volume":"18","author":"Bennasser","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omtm.2017.05.001_bib54","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1172\/JCI43565","article-title":"Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver","volume":"120","author":"Grimm","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2017.05.001_bib55","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1017\/S1355838202024032","article-title":"Gene silencing using micro-RNA designed hairpins","volume":"8","author":"McManus","year":"2002","journal-title":"RNA"},{"key":"10.1016\/j.omtm.2017.05.001_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/108729003321629638","article-title":"Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing","volume":"13","author":"Harborth","year":"2003","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtm.2017.05.001_bib57","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2017.05.001_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/gt.2015.60","article-title":"Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR","volume":"23","author":"Christodoulou","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.stem.2012.07.015","article-title":"How can human pluripotent stem cells help decipher and cure Huntington\u2019s disease?","volume":"11","author":"Perrier","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2017.05.001_bib60","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/stem.1462","article-title":"Embryonic stem cells neural differentiation qualifies the role of Wnt\/\u03b2-Catenin signals in human telencephalic specification and regionalization","volume":"31","author":"Nicoleau","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2017.05.001_bib61","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1242\/dev.117093","article-title":"Activin A directs striatal projection neuron differentiation of human pluripotent stem cells","volume":"142","author":"Arber","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.omtm.2017.05.001_bib62","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1523\/JNEUROSCI.2986-07.2008","article-title":"Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum","volume":"28","author":"Arlotta","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib63","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1242\/dev.126.15.3359","article-title":"Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum","volume":"126","author":"Sussel","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.omtm.2017.05.001_bib64","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1242\/dev.015123","article-title":"NKX2.1 specifies cortical interneuron fate by activating Lhx6","volume":"135","author":"Du","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.omtm.2017.05.001_bib65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0896-6273(01)00211-2","article-title":"Tbr1 regulates differentiation of the preplate and layer 6","volume":"29","author":"Hevner","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2017.05.001_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.conb.2008.05.006","article-title":"The determination of projection neuron identity in the developing cerebral cortex","volume":"18","author":"Leone","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.omtm.2017.05.001_bib67","doi-asserted-by":"crossref","first-page":"13129","DOI":"10.1073\/pnas.1002285107","article-title":"Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex","volume":"107","author":"Bedogni","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.05.001_bib68","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1523\/JNEUROSCI.4131-10.2011","article-title":"Tbr1 and Fezf2 regulate alternate corticofugal neuronal identities during neocortical development","volume":"31","author":"McKenna","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib69","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.1016723108","article-title":"TBR1 directly represses Fezf2 to control the laminar origin and development of the corticospinal tract","volume":"108","author":"Han","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.05.001_bib70","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cne.10654","article-title":"Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain","volume":"460","author":"Ferland","year":"2003","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.omtm.2017.05.001_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuroscience.2003.11.036","article-title":"Foxp1 gene expression in projection neurons of the mouse striatum","volume":"124","author":"Tamura","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtm.2017.05.001_bib72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-8993(98)00724-0","article-title":"Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen","volume":"808","author":"Ouimet","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib73","doi-asserted-by":"crossref","first-page":"e0148680","DOI":"10.1371\/journal.pone.0148680","article-title":"Dominant-negative effects of adult-onset Huntingtin mutations alter the division of human embryonic stem cells-derived neural cells","volume":"11","author":"Lopes","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2017.05.001_bib74","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/mt.2015.128","article-title":"Huntingtin haplotypes provide prioritized target panels for allele-specific silencing in Huntington disease patients of European ancestry","volume":"23","author":"Kay","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib75","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1093\/nar\/gki732","article-title":"Functional polarity is introduced by Dicer processing of short substrate RNAs","volume":"33","author":"Rose","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib76","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1038\/mtna.2012.6","article-title":"Deep sequencing analyses of DsiRNAs reveal the influence of 3\u2032 terminal overhangs on Dicing polarity, strand selectivity, and RNA editing of siRNAs","volume":"1","author":"Zhou","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2017.05.001_bib77","doi-asserted-by":"crossref","first-page":"9255","DOI":"10.1093\/nar\/gks662","article-title":"Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing","volume":"40","author":"Dallas","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib78","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bbrc.2004.02.157","article-title":"An algorithm for selection of functional siRNA sequences","volume":"316","author":"Amarzguioui","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2017.05.001_bib79","doi-asserted-by":"crossref","first-page":"W124","DOI":"10.1093\/nar\/gkh442","article-title":"siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference","volume":"32","author":"Naito","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib80","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2017.05.001_bib81","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/1471-2105-10-392","article-title":"siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect","volume":"10","author":"Naito","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.omtm.2017.05.001_bib82","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1093\/nar\/gks797","article-title":"siSPOTR: a tool for designing highly specific and potent siRNAs for human and mouse","volume":"41","author":"Boudreau","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib83","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2017.05.001_bib84","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2006.05.015","article-title":"Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors","volume":"14","author":"An","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib85","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/gt.2008.123","article-title":"Prevention of interferon-stimulated gene expression using microRNA-designed hairpins","volume":"16","author":"Bauer","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jgm.2626","article-title":"Lentiviral vectors encoding short hairpin RNAs efficiently transduce and knockdown LINGO-1 but induce an interferon response and cytotoxicity in central nervous system neurones","volume":"14","author":"Hutson","year":"2012","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2017.05.001_bib87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/hgtb.2013.016","article-title":"Lentiviral vector-mediated RNA silencing in the central nervous system","volume":"25","author":"Hutson","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2017.05.001_bib88","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/JMN:29:3:185","article-title":"The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA","volume":"29","author":"Lafon","year":"2006","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib89","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1173","article-title":"Induction of an interferon response by RNAi vectors in mammalian cells","volume":"34","author":"Bridge","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2017.05.001_bib90","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1261\/rna.1894510","article-title":"Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity","volume":"16","author":"Ge","year":"2010","journal-title":"RNA"},{"key":"10.1016\/j.omtm.2017.05.001_bib91","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.1190809","article-title":"A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity","volume":"328","author":"Cifuentes","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.omtm.2017.05.001_bib92","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Cheloufi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2017.05.001_bib93","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1261\/rna.032938.112","article-title":"Functional parameters of Dicer-independent microRNA biogenesis","volume":"18","author":"Yang","year":"2012","journal-title":"RNA"},{"key":"10.1016\/j.omtm.2017.05.001_bib94","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1073\/pnas.1006432107","article-title":"Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.05.001_bib95","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1038\/mtna.2014.27","article-title":"Designing Ago2-specific siRNA\/shRNA to avoid competition with endogenous miRNAs","volume":"3","author":"Ma","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2017.05.001_bib96","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1093\/nar\/gkt036","article-title":"Dicer-independent processing of short hairpin RNAs","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.05.001_bib97","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/gt.2011.10","article-title":"Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design","volume":"18","author":"Martin","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib98","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2202-11-20","article-title":"Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system","volume":"11","author":"Ehlert","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib99","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1752-0509-5-19","article-title":"Modeling RNA interference in mammalian cells","volume":"5","author":"Cuccato","year":"2011","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.omtm.2017.05.001_bib100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2377-12-47","article-title":"Huntington\u2019s disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database","volume":"12","author":"Kalathur","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.omtm.2017.05.001_bib101","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib102","doi-asserted-by":"crossref","first-page":"e0143045","DOI":"10.1371\/journal.pone.0143045","article-title":"An effective method to identify shared pathways and common factors among neurodegenerative diseases","volume":"10","author":"Li","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2017.05.001_bib103","doi-asserted-by":"crossref","first-page":"e1002142","DOI":"10.1371\/journal.pbio.1002142","article-title":"Huntingtin is required for epithelial polarity through RAB11A-mediated apical trafficking of PAR3-aPKC","volume":"13","author":"Elias","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtm.2017.05.001_bib104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbagrm.2015.11.005","article-title":"Sequence-non-specific effects generated by various types of RNA interference triggers","volume":"1859","author":"Olejniczak","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2017.05.001_bib105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1432-0436.2004.07202001.x","article-title":"Determinants of interferon-stimulated gene induction by RNAi vectors","volume":"72","author":"Pebernard","year":"2004","journal-title":"Differentiation"},{"key":"10.1016\/j.omtm.2017.05.001_bib106","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib107","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awr333","article-title":"Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum","volume":"135","author":"Grondin","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2017.05.001_bib108","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington\u2019s disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"Lombardi","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtm.2017.05.001_bib109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 editing of the mutant Huntingtin allele in\u00a0vitro and in\u00a0vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib110","first-page":"4566","article-title":"Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2017.05.001_bib111","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1093\/hmg\/ddr263","article-title":"A natural antisense transcript at the Huntington\u2019s disease repeat locus regulates HTT expression","volume":"20","author":"Chung","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2017.05.001_bib112","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib113","doi-asserted-by":"crossref","first-page":"e75896","DOI":"10.1371\/journal.pone.0075896","article-title":"Highly efficient retrograde gene transfer into motor neurons by a lentiviral vector pseudotyped with fusion glycoprotein","volume":"8","author":"Hirano","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2017.05.001_bib114","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jconrel.2016.02.034","article-title":"AAV viral vector delivery to the brain by shape-conforming MR-guided infusions","volume":"240","author":"Bankiewicz","year":"2016","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtm.2017.05.001_bib115","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nn.4332","article-title":"The mouse cortico-striatal projectome","volume":"19","author":"Hintiryan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib116","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/76095","article-title":"Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences","volume":"25","author":"Follenzi","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2017.05.001_bib117","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/10430340050016256","article-title":"Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson\u2019s disease","volume":"11","author":"D\u00e9glon","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib118","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib119","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1523\/JNEUROSCI.20-15-05587.2000","article-title":"Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus","volume":"20","author":"Hottinger","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2017.05.001_bib120","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/mt.2009.48","article-title":"Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform","volume":"17","author":"Amendola","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.05.001_bib121","doi-asserted-by":"crossref","first-page":"24849","DOI":"10.1074\/jbc.274.35.24849","article-title":"A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog","volume":"274","author":"Makeyev","year":"1999","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050117300669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050117300669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:21:19Z","timestamp":1762420879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050117300669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":121,"alternative-id":["S2329050117300669"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2017.05.001","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors.","name":"copyright","label":"Copyright"}]}}